While the anti-aging and life-extending effects of rapamycin, developed as an immunosuppressant, are attracting attention, ...

Eli Lilly is grabbing the lead in the fast-growing diabetes drug market. Eli Lilly (NYSE: LLY) has been on fire over the past ...

In one of the first major tests of the new FDA leadership’s regulatory philosophy toward gene therapies for rare diseases, ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share what their system has done to expand their access to care. The 10 executives featured in this article are ...

The biggest downside of this new treatment is that all participants will need to take immunosuppressant drugs for the rest of their lives. This will reduce the immune system’s ability to recognise the ...

New meta-analysis shows that rapamycin may mimic the benefits of dietary restriction in animals, bringing researchers closer ...

Rapamycin may help prolong life as much as some dietary interventions, according to animal research. These findings, though, ...

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were ...

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...

A new study claims that Rapamycin, a drug that is used as an immunosuppressant to prevent organ transplant rejection might ...